Alexandria Real Estate Equities, Inc.’s Post

Interested in receiving feedback on your pitch, but maybe it’s too early for funding?   Apply to MABA's 1st Pitch Life Science Office Hours today to refine your pitch and connect with life science angel investors. MABA Office Hours provide constructive feedback to companies that may be too early for funding and those who wish to pitch for feedback. - Office hours are open to all to attend but are intended for companies in MABA’s general areas of investment interest (therapeutics, devices, diagnostics, digital health) - Companies pitch for 10 minutes to a panel of MABA investors, followed by 10 minutes of feedback Companies interested in pitching should apply at this link: https://lnkd.in/eF8smZiw #MABA #angelinvestors #lifesciences #1stpitchlifesciences

PFR's Maurizio Grilli has joined Stephen Ryan, founder of Life Sciences Real Estate, to deliver in-depth research on the evolution of the Life Sciences sector in Europe. The 'fast-growing, economic sector' continues to expand as 'European countries and cities continue to compete with each other in different ways to attract talent and investment'. Read more below! #lifesciences #realestate #assetallocation #europeanrealestate #propertyinvestment #lifescienceinvestment

Boston, the San Francisco Bay Area and San Diego are once again the top markets for life sciences commercial real estate in the U.S., with plenty of opportunities for growth as biotech readies for a comeback, according to a new report.

Boston, the San Francisco Bay Area and San Diego are once again the top markets for life sciences commercial real estate in the U.S., with plenty of opportunities for growth as biotech readies for a comeback, according to a new report.

Boston, the San Francisco Bay Area and San Diego are once again the top markets for life sciences commercial real estate in the U.S., with plenty of opportunities for growth as biotech readies for a comeback, according to a new report.

Great to host our latest Quarterly Life Sciences event today with Womble Bond Dickinson (UK) LLP Well done to Ben Foster (DipACB) our Sector Lead and Peter Snaith for putting together a great panel to discuss the funding landscape for Life Sciences business in the North East Thank you to Richard Faulkner Chris McCourt Sam Whitehouse Dr Mike Nicholds & @christian fellowes for their insightful presentations Key takeaways ✅In such an attractive sector, it's crucial to stay open to international sources of capital. ✅Funding can be challenging due to long routes to revenue and profitability, so building a strong management team early on, especially with an experienced CFO, is key to success. This ensures good information and data management, crucial for investors. ✅Spread your pitches wide as many funds struggle with deploying capital. ✅There's a growing appetite for services, diagnostics, and device businesses ✅Having clarity on funding stages, regulatory journey, and validation from sector peers is essential. ✅Having an advisor with a broad network can be a game-changer in navigating these challenges and opening up International Capital

It was a privilege to be the opening speaker at the #biocap Conference today at Alderley Park. I was happy to share that angel investors typically contribute around 10% of all UK life science investments (Beauhurst) and that 30%+ of angels surveyed by the UK Business Angels Association had invested in lifesciences in their portfolios. The best I saved until last.... Whilst the sector, like the wider environment, is experiencing some investment headwinds in 2022/23, the number of investments going to co-led and female founded life-science teams is INCREASING. ***No of deals in 2021 . All male 384. Mixed 91 and All female 36 ***No of deals in 2022. All male 345. Mixed 100. All female 41. ***There are six regions in the UK where more than 30% of the total number of investments in 2022 went to mixed and all female teams; South East, Scotland, North West, South West, West Midlands and North East. (Source Beauhurst). A positive message for the sector, investment community and for all female founders. Thanks to Bionow for a great event. #lifesciences #earlystageinvestment #angelinvesting #femalefounders #investment #medtech #pharma Shaun GradySarah HollandClaire Thompson Vivien Badaut Jesse Gray Carrie AmblerJan RogersHenrietta Boyd Jordan Dargue Jessica JacksonFiona Hatch Emma Johnson Laura Sisson, CFA Jenny Barnett Sonal Bajpai Gemma Sturt

One of the most interesting areas of investment at Blackstone is life sciences.  The need for capital and know-how to optimize clinical trials continues to grow and outpace the availability of capital. Here’s 5 key takeaways from Nick Galakatos who leads our life sciences business. 

Are you an investor and interested in supporting our local life sciences ecosystem? Our upcoming #LifeSciencesSummit is only possible with the participation of angel investors to help our local life sciences companies raise capital and fast-track their success! We know what you're thinking - investing is complicated and requires a lot of professional level due diligence, and the life sciences regulatory environment adds even more complexity. That's why we have prepared a unique session to tell you everything you need to know about investing in the life sciences and set you up for closing a successful deal! Join API and Startup TNT at our Angel 101 online sessions with HaloHealth, this January 16 and 18. Whether you're new or experienced in investing, these sessions will help you to: 🔍 Gain valuable insights into the current state of investing in life sciences. 📈 Discover the latest trends shaping the life sciences industry. 💡 Learn how to identify lucrative investment opportunities. 🤝 Build connections within a vibrant community of investors and professionals. 🌐 Expand your network and uncover potential partnerships. Don't miss out on this incredible opportunity! Secure your spot now 👉 https://lnkd.in/gjxTYzAV

🔔 REMINDER: Somnus Investors meeting Location: Bath Date: 23rd February Open to: anyone who is interested in Somnus and thinking about investing Come and hear from and meet the team. Our investors come from three main backgrounds: ➡45 doctors who recognise the need for the products we are developing and are eager to use them day to day ➡Angels who investor in medtech or life science companies A cornerstone investor; an Emerging Markets Investment Trust, listed on the ➡Main Market of the London Stock Exchange. There will be presentations about the progress Somnus is making and the plans the Directors have for accessing key markets in the near future. There will also be opportunities to talk to a range of existing investors, as well as a Q&A with the senior team and the Advisory Board. #medtech #investmentopportunity